Displaying items by tag: department of neurosurgery

A UAB surgeon has received the Congress of Neurological Surgeons’ most prestigious award.
The goal is an early warning system to block incipient seizures for patients where medications have failed.
Early results for a UAB-developed viral immunotherapy to treat brain tumors in children demonstrate safety and tolerability in Phase I studies.
The dying cells send signals to recipient tumor cells to increase aggressiveness, motility, and resistance to radiation or chemotherapy.
Both dogs and people get brain tumors, and UAB researchers are studying a therapy developed for humans that might also work on dogs.
A business officer in the UAB Dept. of Neurosurgery becomes a patient when co-workers diagnose a blood clot in his brain.
Reintegration into school has been a noticeably neglected area of focus in concussion research, particularly in comparison to research on return-to-play. When and how a student should be fully integrated into the classroom are just two questions UAB and Children’s of Alabama researchers are looking to answer.
This potential chemotherapeutic agent to treat glioblastoma — a primary brain tumor with dismal survival rates — is a novel small molecule inhibitor.
There will be more than 33,000 brain tumors diagnosed in Americans this year, according to the National Cancer Institute; but a UAB neurosurgeon says advances in treatment paint a brighter outlook than in years past.
UAB neurosurgery’s commitment to quality care is reflected in outcomes that beat national averages in key measurements.
A seven-year effort led by a UAB neurologist has established the first guidelines for the use of fMRI in epilepsy surgery.

This rapidly fatal brain cancer has seen only two improvements in therapy in 30 years, and research findings are pointing toward a unique new human clinical trial in 2017. 

UAB investigators have won a prestigious White House BRAIN Initiative grant to study the potential benefits of new technology coupled with newly discovered biomarkers in deep brain stimulation for Parkinson’s disease.
Page 2 of 3